1Sacco RL, Roberts JK, Jacobs BS. Homocystein as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology, 1998, 17:167-173.
2Ueland PM, Refsum H, Stable SP. Total homocystein in plasma or serum: methods and clinical application. Clin Chem, 1993, 39: 1764-1779.
3Frosst P, Blam HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation methylenetetrahydrofolete. Nat Genet, 1995, 10: 111-113.
6Sanahuja J,Marti Fabregas J,Marti Vilalta JL.Carotid thrombus ahdcerebral infarction as the initial clinical manifesyation of polycythemia[J].Medical Recapitulate,2007,13(9):706.
7Yoo JH.Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia[J].Arterioscler Thromb Vase Biol,2000,20(8):1921-1925.
8Moller J.A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia[J].Scand J Clin Lab Invest,2000,60(6):491.
9Fallon UB,Virtamo J,Young I,et al.Homocysteine and cerebral infarctionin finnish male smokers[J].Stroke,2003,34(6):1359-1363.
10L. Parnetti,V. Caso,A. Santucci,F. Corea,A. Lanari,A. Floridi,C. Conte,T. Bottiglieri. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke[J] 2004,Neurological Sciences(1):13～17
